AKAM vs AUPH · P/E 27, rev $2.17B vs P/E 28, rev $160.9M
Akamai Technologies Inc (AKAM) versus Aurinia Pharmaceuticals Inc (AUPH) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Not investment advice. Open the AKAM and AUPH stock pages for the full models.
Not investment advice.